000 | 01535 a2200409 4500 | ||
---|---|---|---|
005 | 20250511122604.0 | ||
264 | 0 | _c19791218 | |
008 | 197912s 0 0 eng d | ||
022 | _a0090-1229 | ||
024 | 7 |
_a10.1016/0090-1229(79)90082-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNékám, K | |
245 | 0 | 0 |
_aEffects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent cytotoxic activity in humans. _h[electronic resource] |
260 |
_bClinical immunology and immunopathology _cAug 1979 |
||
300 |
_a407-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
650 | 0 | 4 |
_aCandidiasis, Cutaneous _ximmunology |
650 | 0 | 4 |
_aCrohn Disease _ximmunology |
650 | 0 | 4 |
_aHerpesviridae Infections _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _ximmunology |
650 | 0 | 4 | _aLeukocytes |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _ximmunology |
650 | 0 | 4 |
_aMelanoma _ximmunology |
650 | 0 | 4 |
_aReceptors, Fc _xanalysis |
650 | 0 | 4 |
_aSezary Syndrome _ximmunology |
650 | 0 | 4 |
_aTransfer Factor _xtherapeutic use |
650 | 0 | 4 |
_aWiskott-Aldrich Syndrome _ximmunology |
700 | 1 | _aLáng, I | |
700 | 1 | _aTörök, K | |
700 | 1 | _aKalmár, L | |
700 | 1 | _aGergely, P | |
700 | 1 | _aPetrányi, G | |
773 | 0 |
_tClinical immunology and immunopathology _gvol. 13 _gno. 4 _gp. 407-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-1229(79)90082-5 _zAvailable from publisher's website |
999 |
_c251694 _d251694 |